Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases

Hydroxychloroquine is widely prescribed in systemic lupus erythematosus. Dermatologic adverse drug reactions are rare but can mimic a disease specific manifestation of lupus. Exceptionally, Sweet's syndrome, or acute febrile neutrophilic dermatosis, may be drug-induced. Two patients aged 31 and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	La revue de medecine interne 2020-04, Vol.41 (4), p.289
Hauptverfasser:	Bodard, Q, Carre, D, Chenal, P, Zarnitsky, C, Midhat, M, Litrowski, N
Format:	Artikel
Sprache:	fre
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Adult Diagnosis, Differential Drug Substitution Female Humans Hydroxychloroquine - adverse effects Hydroxychloroquine - therapeutic use Lupus Erythematosus, Systemic - drug therapy Sjogren's Syndrome - drug therapy Sweet Syndrome - chemically induced Sweet Syndrome - diagnosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	4
container_start_page	289
container_title	La revue de medecine interne
container_volume	41
creator	Bodard, Q Carre, D Chenal, P Zarnitsky, C Midhat, M Litrowski, N
description	Hydroxychloroquine is widely prescribed in systemic lupus erythematosus. Dermatologic adverse drug reactions are rare but can mimic a disease specific manifestation of lupus. Exceptionally, Sweet's syndrome, or acute febrile neutrophilic dermatosis, may be drug-induced. Two patients aged 31 and 42 years were treated with hydroxychloroquine for systemic lupus and Sjogren's syndrome, respectively. Three weeks after starting treatment, they had a febrile, purple and erythematous papular rash of the trunk and limbs. There was a biological inflammatory syndrome and skin biopsy disclosed an infiltrate of the dermis rich in neutrophils. Lesions regressed after stopping hydroxychloroquine and introducing systemic corticosteroid therapy. Allergologic tests discussed the differential diagnosis with a delayed-type hypersensitivity reaction. We report two exceptional cases of drug-induced Sweet's syndrome related to hydroxychloroquine treatment in autoimmune rheumatic diseases.
doi_str_mv	10.1016/j.revmed.2019.08.010
format	Article
fullrecord	<record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_31540835</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31540835</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-1108e877bb58f467a30f053107549bbf474eee6bb364239d9d183445517e695a3</originalsourceid><addsrcrecordid>eNo1j81KxDAURoMgzjj6BiLZuWq9t0ma1N0wjn8MuFDXQ9PcOh06bU1atW9vQV19cD44cBi7QIgRML3ex54-D-TiBDCLwcSAcMTmqFMTCUySGTsNYQ8wYcxO2EygkmCEmrOnWz-8R1XjhoIcf_ki6q8CD2PjfHsg7qnO--noW74bJ_Q9Fru69e3HUDV0w5e2HXqe8CIPFM7YcZnXgc7_dsHe7tavq4do83z_uFpuoi5B7CNEMGS0tlaZUqY6F1CCEghayczaUmpJRKm1IpWJyFzm0AgplUJNaaZysWCXv95usFPztvPVIffj9j9K_ACe6U29</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bodard, Q ; Carre, D ; Chenal, P ; Zarnitsky, C ; Midhat, M ; Litrowski, N</creator><creatorcontrib>Bodard, Q ; Carre, D ; Chenal, P ; Zarnitsky, C ; Midhat, M ; Litrowski, N</creatorcontrib><description>Hydroxychloroquine is widely prescribed in systemic lupus erythematosus. Dermatologic adverse drug reactions are rare but can mimic a disease specific manifestation of lupus. Exceptionally, Sweet's syndrome, or acute febrile neutrophilic dermatosis, may be drug-induced. Two patients aged 31 and 42 years were treated with hydroxychloroquine for systemic lupus and Sjogren's syndrome, respectively. Three weeks after starting treatment, they had a febrile, purple and erythematous papular rash of the trunk and limbs. There was a biological inflammatory syndrome and skin biopsy disclosed an infiltrate of the dermis rich in neutrophils. Lesions regressed after stopping hydroxychloroquine and introducing systemic corticosteroid therapy. Allergologic tests discussed the differential diagnosis with a delayed-type hypersensitivity reaction. We report two exceptional cases of drug-induced Sweet's syndrome related to hydroxychloroquine treatment in autoimmune rheumatic diseases.</description><identifier>EISSN: 1768-3122</identifier><identifier>DOI: 10.1016/j.revmed.2019.08.010</identifier><identifier>PMID: 31540835</identifier><language>fre</language><publisher>France</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Adult ; Diagnosis, Differential ; Drug Substitution ; Female ; Humans ; Hydroxychloroquine - adverse effects ; Hydroxychloroquine - therapeutic use ; Lupus Erythematosus, Systemic - drug therapy ; Sjogren's Syndrome - drug therapy ; Sweet Syndrome - chemically induced ; Sweet Syndrome - diagnosis</subject><ispartof>La revue de medecine interne, 2020-04, Vol.41 (4), p.289</ispartof><rights>Copyright © 2019 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31540835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bodard, Q</creatorcontrib><creatorcontrib>Carre, D</creatorcontrib><creatorcontrib>Chenal, P</creatorcontrib><creatorcontrib>Zarnitsky, C</creatorcontrib><creatorcontrib>Midhat, M</creatorcontrib><creatorcontrib>Litrowski, N</creatorcontrib><title>Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><description>Hydroxychloroquine is widely prescribed in systemic lupus erythematosus. Dermatologic adverse drug reactions are rare but can mimic a disease specific manifestation of lupus. Exceptionally, Sweet's syndrome, or acute febrile neutrophilic dermatosis, may be drug-induced. Two patients aged 31 and 42 years were treated with hydroxychloroquine for systemic lupus and Sjogren's syndrome, respectively. Three weeks after starting treatment, they had a febrile, purple and erythematous papular rash of the trunk and limbs. There was a biological inflammatory syndrome and skin biopsy disclosed an infiltrate of the dermis rich in neutrophils. Lesions regressed after stopping hydroxychloroquine and introducing systemic corticosteroid therapy. Allergologic tests discussed the differential diagnosis with a delayed-type hypersensitivity reaction. We report two exceptional cases of drug-induced Sweet's syndrome related to hydroxychloroquine treatment in autoimmune rheumatic diseases.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Adult</subject><subject>Diagnosis, Differential</subject><subject>Drug Substitution</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxychloroquine - adverse effects</subject><subject>Hydroxychloroquine - therapeutic use</subject><subject>Lupus Erythematosus, Systemic - drug therapy</subject><subject>Sjogren's Syndrome - drug therapy</subject><subject>Sweet Syndrome - chemically induced</subject><subject>Sweet Syndrome - diagnosis</subject><issn>1768-3122</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j81KxDAURoMgzjj6BiLZuWq9t0ma1N0wjn8MuFDXQ9PcOh06bU1atW9vQV19cD44cBi7QIgRML3ex54-D-TiBDCLwcSAcMTmqFMTCUySGTsNYQ8wYcxO2EygkmCEmrOnWz-8R1XjhoIcf_ki6q8CD2PjfHsg7qnO--noW74bJ_Q9Fru69e3HUDV0w5e2HXqe8CIPFM7YcZnXgc7_dsHe7tavq4do83z_uFpuoi5B7CNEMGS0tlaZUqY6F1CCEghayczaUmpJRKm1IpWJyFzm0AgplUJNaaZysWCXv95usFPztvPVIffj9j9K_ACe6U29</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Bodard, Q</creator><creator>Carre, D</creator><creator>Chenal, P</creator><creator>Zarnitsky, C</creator><creator>Midhat, M</creator><creator>Litrowski, N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>202004</creationdate><title>Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases</title><author>Bodard, Q ; Carre, D ; Chenal, P ; Zarnitsky, C ; Midhat, M ; Litrowski, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-1108e877bb58f467a30f053107549bbf474eee6bb364239d9d183445517e695a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2020</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Adult</topic><topic>Diagnosis, Differential</topic><topic>Drug Substitution</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxychloroquine - adverse effects</topic><topic>Hydroxychloroquine - therapeutic use</topic><topic>Lupus Erythematosus, Systemic - drug therapy</topic><topic>Sjogren's Syndrome - drug therapy</topic><topic>Sweet Syndrome - chemically induced</topic><topic>Sweet Syndrome - diagnosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bodard, Q</creatorcontrib><creatorcontrib>Carre, D</creatorcontrib><creatorcontrib>Chenal, P</creatorcontrib><creatorcontrib>Zarnitsky, C</creatorcontrib><creatorcontrib>Midhat, M</creatorcontrib><creatorcontrib>Litrowski, N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bodard, Q</au><au>Carre, D</au><au>Chenal, P</au><au>Zarnitsky, C</au><au>Midhat, M</au><au>Litrowski, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2020-04</date><risdate>2020</risdate><volume>41</volume><issue>4</issue><spage>289</spage><pages>289-</pages><eissn>1768-3122</eissn><abstract>Hydroxychloroquine is widely prescribed in systemic lupus erythematosus. Dermatologic adverse drug reactions are rare but can mimic a disease specific manifestation of lupus. Exceptionally, Sweet's syndrome, or acute febrile neutrophilic dermatosis, may be drug-induced. Two patients aged 31 and 42 years were treated with hydroxychloroquine for systemic lupus and Sjogren's syndrome, respectively. Three weeks after starting treatment, they had a febrile, purple and erythematous papular rash of the trunk and limbs. There was a biological inflammatory syndrome and skin biopsy disclosed an infiltrate of the dermis rich in neutrophils. Lesions regressed after stopping hydroxychloroquine and introducing systemic corticosteroid therapy. Allergologic tests discussed the differential diagnosis with a delayed-type hypersensitivity reaction. We report two exceptional cases of drug-induced Sweet's syndrome related to hydroxychloroquine treatment in autoimmune rheumatic diseases.</abstract><cop>France</cop><pmid>31540835</pmid><doi>10.1016/j.revmed.2019.08.010</doi></addata></record>
fulltext	fulltext
identifier	EISSN: 1768-3122
ispartof	La revue de medecine interne, 2020-04, Vol.41 (4), p.289
issn	1768-3122
language	fre
recordid	cdi_pubmed_primary_31540835
source	MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects	Adrenal Cortex Hormones - therapeutic use Adult Diagnosis, Differential Drug Substitution Female Humans Hydroxychloroquine - adverse effects Hydroxychloroquine - therapeutic use Lupus Erythematosus, Systemic - drug therapy Sjogren's Syndrome - drug therapy Sweet Syndrome - chemically induced Sweet Syndrome - diagnosis
title	Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A34%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-induced%20Sweet's%20syndrome%20related%20to%20hydroxychloroquine:%20About%202%20cases&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Bodard,%20Q&rft.date=2020-04&rft.volume=41&rft.issue=4&rft.spage=289&rft.pages=289-&rft.eissn=1768-3122&rft_id=info:doi/10.1016/j.revmed.2019.08.010&rft_dat=%3Cpubmed%3E31540835%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31540835&rfr_iscdi=true